SAFETY AND EFFICACY OF PROLONGED CYTOMEGALOVIRUS PROPHYLAXIS WITH INTRAVENOUS GANCICLOVIR IN PEDIATRIC AND YOUNG ADULT LUNG TRANSPLANT RECIPIENTS

BACKGROUND: Cytomegalovirus (CMV) infection causes morbidity and mortality after transplantation. Despite a wide range of prevention strategies among pediatric lung transplant programs, the optimal duration of prophylactic therapy against CMV infection in pediatric lung transplantation is unknown. O...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Spivey, John F., Jewell, Dana, Sweet, Stuart, Storch, Gregory A., Hayashi, Robert J., Huddleston, Charles B., Danziger-Isakov, Lara A.
Formato: Artigo
Idioma:Inglês
Publicado: 2007
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1930168/
https://ncbi.nlm.nih.gov/pubmed/17430489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1399-3046.2006.00626.x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares